Science
Science Stories
Study: Biomarker may predict response to immunotherapy in liver cancer – World News Network
According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether individuals with hepatocellular carcinoma, a kind of liver cancer, may benefit from immunotherapy.
Researchers discover alternate method to study changes during DNA replication process – World News Network
Researchers at Colorado State University discovered an alternative way for studying alterations during the DNA replication process in lab settings using genetically modified yeast. The novel methodology provides a clearer picture than current pharmacological methods for understanding cell cycle arrest, a fundamental mechanism critical to cancer treatment and genetic concerns.
Study finds how Alzheimer’s disease may damage brain in two phases – World News Network
Alzheimer's disease may cause brain damage in two stages, according to new research supported by the National Institutes of Health (NIH) that uses sophisticated brain mapping methods.
Study finds new ways to prevent, treat type 2 diabetes – World News Network
Pancreatic cells, like human cells, have a limit to how much stress they can handle before they start to break down. Through overstimulation of these cells, certain stresses like inflammation and hyperglycemia lead to the onset of type 2 diabetes.
Researchers discover that unique immune cells stop metastatic cancer – World News Network
The majority of cancer deaths are caused by metastatic disease, which occurs when cancer spreads from the primary tumour to other areas of the body. and researchers understand how cancer cells escape the primary location to seed new tumours, it is unclear why some cancer cells produce new tumours decades…
Researchers identify new potential treatment for cardiac arrhythmias – World News Network
A recent study by researchers at the University of Arizona College of Medicine - Phoenix and the University of California Davis Health discovered a new target for developing a medication to treat atrial fibrillation, the most prevalent kind of irregular heart rhythm.